CORAL SPRINGS, FL--(Marketwire - Sep 11, 2012) - FinancialNewsMedia.com "stocks to watch" for today: Pazoo, Inc. (OTCBB: PZOO), Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS), Transax International Ltd. (PINKSHEETS: TNSX), Cell Therapeutics, Inc. (NASDAQ: CTIC)
News Update issued for PZOO.OB: Pazoo Unveils the "MAX" Line of Health, Wellness and Nutri-Ceutical Products. PZOO also received news late last week it has secured DTC Eligibility.
Headline News: Pazoo, Inc. (OTCBB: PZOO) is excited to present for distribution the MAX Line of Health, Wellness and Nutri-Ceutical Products. The initial product releases will be the MAXPLUS Multivitamin Powered by CELLMAX and CELLMAX Stem cell nutrition concentrate. To follow in the 4th quarter of this year will be a water oxygenator for people and one for pets. By the end of 2012 or early in the 1st quarter of 2013 an anti-aging product will be added to the MAX Line as well as a MAX line product for aches and pains. Trademark applications have been filed to protect the branding of this new line allowing Pazoo to bring these products to market.
See this news as the latest Video Press Release on Youtube.com - http://youtu.be/Y0kG-zQbg7k
The Creator of these products has already generated an extremely positive reaction and has testimonials from people with very serious ailments as to the incredible beneficial results from using these products. Not only are several of these products patented, but there is ample inventory for immediate introduction to the market.
Pazoo expects to quickly ramp up revenues with the introduction of these products into the market initially through direct response programs later this month. Distribution into and through brick and mortar retail is expected in the second quarter of 2013. Pazoo expects to have at least ten products in direct response and retail distribution channels before the end of June 2013.
David M. Cunic, CEO of Pazoo, Inc., stated, "I have never been more excited in my life to be involved with such a dynamic company that is on the cutting edge of providing health and wellness information, products and services to people and their pets. We really are going to make a positive difference in the lives of so many people and their pets -- just fantastic, really fantastic!"
For more details and to read the entire press release issued by PZOO that includes the full company disclosures please go to http://www.financialnewsmedia.com/stock-investing-business-investing-news/featured-news.php?id=205
Don't miss out on future alerts of this emerging company, sign up for our free News Alerts now at http://www.financialnewsmedia.com.
Get an edge on the market with our Premium News Alerts that are FREE for a limited time at http://www.financialnewsmedia.com.
Follow us on Facebook: http://www.facebook.com/financialnewsmedia and Twitter: http://twitter.com/FNMgroup
Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) today announced that it will implement a one-time 225-patient sample size increase to its Phase 3 VALOR trial of vosaroxin in acute myeloid leukemia (AML), bringing target enrollment to 675 patients.
Transax International Ltd. (PINKSHEETS: TNSX) provides information network solutions for healthcare providers and health insurance companies. The Company's products support the real-time automation of patient eligibility verifications, authorizations, claims processing, and payment functions that are currently performed manually
Cell Therapeutics, Inc. (NASDAQ: CTIC), a company focused on translating science into novel cancer therapies, today announced the initiation of the commercial launch of Pixuvri in the European Union with entry into Sweden, Denmark and Finland in September, to be followed by Austria and Norway in early October 2012 and Germany, United Kingdom and the Netherlands in November 2012.
If you're a company interested in having FN Media Group assist you with creating a greater awareness for your next news release utilizing our multi-media and leading edge outreach solutions, contact us now at email@example.com
DISCLAIMER: FN Media Group LLC (FNMG) owns and operates FinancialNewsMedia.com (FNM) which disseminates electronic information through multiple online media channels. FNMG's intended purposes are to deliver market updates and news alerts issued from private and publicly trading companies as well as providing coverage and increased awareness for companies that issue press to the public via online newswires. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. An offer to buy or sell can be made only with accompanying disclosure documents from the company offering or selling securities and only in the states and provinces for which they are approved. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. Information in this release is derived from a variety of sources that may or may not include the referenced company's publicly disseminated information. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. While this information is believed to be reliable, such reliability cannot be guaranteed. FNMG disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. This release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.
This release is not without bias, and is considered a conflict of interest if compensation has been received by FNMG for its dissemination. To comply with Section 17(b) of the Securities Act of 1933, FNMG shall always disclose any compensation it has received, or expects to receive in the future, for the dissemination of the information found herein on behalf of one or more of the companies mentioned in this release. For disseminating this release, FNMG was compensated seven hundred fifty dollars for this news release on behalf of Pazoo, Inc. (OTCBB: PZOO). FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.